Ph1 Lobeline Interaction Study - 1

Status unconfirmed · Phase 1

Conditions studied: Methamphetamine Dependence

In brief

The purpose of this study is to determine if there are significant cardiovascular or other interactions between sublingual lobeline and intravenous methamphetamine.

Key facts

Study ID

NCT00439504

Run by

National Institute on Drug Abuse (NIDA)

People needed

10

Last updated by the study team

2017-01-11

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Be between the ages of 18 and 45 years of age
• Be in general good health with a history of methamphetamine (MA) abuse (but not dependence)
• If female and of child bearing potential, agrees to use birth control
• Be able to understand and provide written informed consent
• Have a body mass index between 18 and 30
• Have reported use of (MA) during the past three months without experiencing adverse consequence plus a life time MA or amphetamine use history of at least four occasions of use
• Have a negative drug test (barbiturates, benzodiazepines, amphetamines, opiates, cocaine, cannabinoids, ethanol) at screening and at the time of admission

You may not qualify if…

• Please contact site for details

Where it is running

• Langley Porter Psychiatric Institute — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.